Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor or vanzacaftor+tezacaftor+deutivacaftor - continuing authority application form (PB287)

Use this form to apply to continue PBS-subsidised treatment with elexacaftor+tezacaftor+ivacaftor for patients at least 2 years of age, or vanzacaftor+tezacaftor+deutivacaftor for patients at least 6 years of age with cystic fibrosis.

Page last updated: 1 February 2026.
QC 51932